Comparison of 3-year outcomes of photodynamic therapy combined with intravitreal ranibizumab or aflibercept for polypoidal choroidal vasculopathy in a European cohort

PURPOSE: Combined use of photodynamic therapy (PDT) with intravitreal anti-vascular endothelial growth factors (anti-VEGF) agents, such as ranibizumab (IVR) or aflibercept (IVA), has been shown to be effective for treating polypoidal choroidal vasculopathy (PCV). However, it is currently not well es...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Siyin, Chhabra, Ramandeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Retinal Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581849/
https://www.ncbi.nlm.nih.gov/pubmed/35678837
http://dx.doi.org/10.1007/s00417-022-05724-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581849/
https://www.ncbi.nlm.nih.gov/pubmed/35678837
http://dx.doi.org/10.1007/s00417-022-05724-4

Ejemplares similares